DMP — Dermapharm Holding SE Cashflow Statement
0.000.00%
Last trade - 00:00
- €1.69bn
- €2.61bn
- €1.14bn
- 50
- 48
- 16
- 28
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 110 | 125 | 293 | 216 | 106 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 10.5 | 14 | 3.26 | 22.1 | 68 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -67.3 | -51.2 | -91.1 | -44.7 | -57.2 |
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 101 | 132 | 250 | 289 | 219 |
Capital Expenditures | -46.4 | -40.8 | -61.2 | -39 | -41.5 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -336 | -65.1 | -68.1 | -60 | -374 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -382 | -106 | -129 | -99 | -415 |
Financing Cash Flow Items | -7.17 | -22.7 | -7.69 | -11.7 | -33.1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 184 | -14.1 | -81 | -200 | 205 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -97.4 | 11.3 | 41.1 | -10.4 | 7.71 |